XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 4,151 $ 4,532 $ 11,634 $ 13,442
Cost of revenue (COR) 1,677 1,717 4,854 4,854
Gross profit 2,474 2,815 6,780 8,588
Research and development (R&D) 492 471 1,468 1,403
Selling, general and administrative (SG&A) 428 452 1,348 1,387
Restructuring charges/other 0 0 (124) 0
Operating profit 1,554 1,892 4,088 5,798
Other income (expense), net (OI&E) 131 128 384 327
Interest and debt expense 131 98 378 255
Income before income taxes 1,554 1,922 4,094 5,870
Provision for income taxes 192 213 500 731
Net income $ 1,362 $ 1,709 $ 3,594 $ 5,139
Earnings per common share (EPS):        
Basic (in dollars per share) $ 1.48 $ 1.87 $ 3.92 $ 5.63
Diluted (in dollars per share) $ 1.47 $ 1.85 $ 3.89 $ 5.58
Average shares outstanding:        
Basic (in shares) 913 908 912 908
Diluted (in shares) 920 916 919 916
Diluted EPS:        
Net income $ 1,362 $ 1,709 $ 3,594 $ 5,139
Income allocated to RSUs (7) (10) (18) (26)
Income allocated to common stock for diluted EPS $ 1,355 $ 1,699 $ 3,576 $ 5,113